Pregabalin Extended Release

Product NDC
50228-464
11-digit product format
502280464
Labeler code
50228
Product ID
50228-464_e90bfe09-9adb-03c0-e053-2a95a90a061e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
PREGABALIN
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
ScieGen Pharmaceuticals, INC.
Application
ANDA215675
Marketing category
ANDA
Marketing start
2022-09-14
Substance
PREGABALIN
Active strength
330 mg/1
DEA schedule
CV
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A215675-001PREGABALINPREGABALIN82.5MGTABLET, EXTENDED RELEASE / ORAL2022-09-14
A215675-002PREGABALINPREGABALIN165MGTABLET, EXTENDED RELEASE / ORAL2022-09-14
A215675-003PREGABALINPREGABALIN330MGTABLET, EXTENDED RELEASE / ORAL2022-09-14

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 78 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A215675-001PREGABALIN82.5MGTABLET, EXTENDED RELEASE / ORAL2022-09-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02A215675-002PREGABALIN165MGTABLET, EXTENDED RELEASE / ORAL2022-09-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02A215675-003PREGABALIN330MGTABLET, EXTENDED RELEASE / ORAL2022-09-14011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215675-001PREGABALIN82.5MGTABLET, EXTENDED RELEASE / ORAL2022-09-1431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215675-002PREGABALIN165MGTABLET, EXTENDED RELEASE / ORAL2022-09-1431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215675-003PREGABALIN330MGTABLET, EXTENDED RELEASE / ORAL2022-09-1431067a03dcf5…
2025-08-23 18:47 UTC2025-08A215675-001PREGABALIN82.5MGTABLET, EXTENDED RELEASE / ORAL2022-09-146a471c1ec25d…
2025-08-23 18:47 UTC2025-08A215675-002PREGABALIN165MGTABLET, EXTENDED RELEASE / ORAL2022-09-146a471c1ec25d…
2025-08-23 18:47 UTC2025-08A215675-003PREGABALIN330MGTABLET, EXTENDED RELEASE / ORAL2022-09-146a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215675-001PREGABALIN82.5MGTABLET, EXTENDED RELEASE / ORAL2022-09-14fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215675-002PREGABALIN165MGTABLET, EXTENDED RELEASE / ORAL2022-09-14fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215675-003PREGABALIN330MGTABLET, EXTENDED RELEASE / ORAL2022-09-14fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215675-001PREGABALIN82.5MGTABLET, EXTENDED RELEASE / ORAL2022-09-14b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215675-002PREGABALIN165MGTABLET, EXTENDED RELEASE / ORAL2022-09-14b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215675-003PREGABALIN330MGTABLET, EXTENDED RELEASE / ORAL2022-09-14b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A215675-001PREGABALIN82.5MGTABLET, EXTENDED RELEASE / ORAL2022-09-1403ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A215675-002PREGABALIN165MGTABLET, EXTENDED RELEASE / ORAL2022-09-1403ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A215675-003PREGABALIN330MGTABLET, EXTENDED RELEASE / ORAL2022-09-1403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A215675-001PREGABALIN82.5MGTABLET, EXTENDED RELEASE / ORAL2022-09-142680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A215675-002PREGABALIN165MGTABLET, EXTENDED RELEASE / ORAL2022-09-142680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A215675-003PREGABALIN330MGTABLET, EXTENDED RELEASE / ORAL2022-09-142680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A215675-001PREGABALIN82.5MGTABLET, EXTENDED RELEASE / ORAL2022-09-145bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A215675-002PREGABALIN165MGTABLET, EXTENDED RELEASE / ORAL2022-09-145bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A215675-003PREGABALIN330MGTABLET, EXTENDED RELEASE / ORAL2022-09-145bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A215675-001PREGABALIN82.5MGTABLET, EXTENDED RELEASE / ORAL2022-09-14d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A215675-002PREGABALIN165MGTABLET, EXTENDED RELEASE / ORAL2022-09-14d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A215675-003PREGABALIN330MGTABLET, EXTENDED RELEASE / ORAL2022-09-14d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A215675-001PREGABALIN82.5MGTABLET, EXTENDED RELEASE / ORAL2022-09-14d06236e962d9…
2024-10-29 15:01 UTC2024-10A215675-002PREGABALIN165MGTABLET, EXTENDED RELEASE / ORAL2022-09-14d06236e962d9…
2024-10-29 15:01 UTC2024-10A215675-003PREGABALIN330MGTABLET, EXTENDED RELEASE / ORAL2022-09-14d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A215675-001PREGABALIN82.5MGTABLET, EXTENDED RELEASE / ORAL2022-09-1479d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A215675-002PREGABALIN165MGTABLET, EXTENDED RELEASE / ORAL2022-09-1479d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A215675-003PREGABALIN330MGTABLET, EXTENDED RELEASE / ORAL2022-09-1479d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A215675-001PREGABALIN82.5MGTABLET, EXTENDED RELEASE / ORAL2022-09-14301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A215675-002PREGABALIN165MGTABLET, EXTENDED RELEASE / ORAL2022-09-14301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A215675-003PREGABALIN330MGTABLET, EXTENDED RELEASE / ORAL2022-09-14301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A215675-001PREGABALIN82.5MGTABLET, EXTENDED RELEASE / ORAL2022-09-141e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A215675-002PREGABALIN165MGTABLET, EXTENDED RELEASE / ORAL2022-09-141e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A215675-003PREGABALIN330MGTABLET, EXTENDED RELEASE / ORAL2022-09-141e350fbaab3a…
2024-05-31 18:47 UTC2024-05A215675-001PREGABALIN82.5MGTABLET, EXTENDED RELEASE / ORAL2022-09-148072bd15b7f6…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2023-05-13 08:27 UTC2023-05A215675-001AB1053a50430f4f…
2023-05-13 08:27 UTC2023-05A215675-002AB1053a50430f4f…
2023-05-13 08:27 UTC2023-05A215675-003AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A215675-001AB13bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01A215675-002AB13bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01A215675-003AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A215675-001AB13a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A215675-002AB13a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A215675-003AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A215675-001AB1f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10A215675-002AB1f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10A215675-003AB1f41ea6bd6efb…

Additional Listing Data#

Finished product
Yes
Brand name base
Pregabalin Extended Release
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
PREGABALIN330 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
55JG375S6MInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1988974Internal RxNorm lookup
1988977Internal RxNorm lookup
1988980Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1544a657-353c-47f8-96ac-a63fa78373f0Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
441d8579-bd15-4585-93f4-9de3db2d851dProduct name420251114
594e2c86-3079-4e6e-96c9-48f7a8afc78dProduct name120230718
a62a50ac-1535-4461-9768-8ae703e2e9fbProduct name120210525
004d1029-ec13-fc89-74f4-3907cf5b6602Product name220140523
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877Product name120140508
bc07ef78-e82d-0c19-31f4-31f263780582Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50228-464-05Pregabalin Extended Release500 in 1 BOTTLETABLET, FILM COATED, EXTENDED RE5001
50228-464-30Pregabalin Extended Release30 in 1 BOTTLETABLET, FILM COATED, EXTENDED RE301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50228-464PREGABALIN EXTENDED RELEASE (PREGABALIN) TABLET, FILM COATED, EXTENDED RELEASE [SCIEGEN PHARMACEUTICALS, INC.]1Current NDC, Legacy NDC, 2 package rows20220920_1544a657-353c-47f8-96ac-a63fa78373f0.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Pregabalin Extended ReleasePREGABALINScieGen Pharmaceuticals, INC.1544a657-353c-47f8-96ac-a63fa78373f02022-09-19Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215675
application number: ANDA215675
ndc (product): 50228-464

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1988974pregabalin 165 MG 24HR Extended Release Oral TabletPSN1544a657-353c-47f8-96ac-a63fa78373f01
1988977pregabalin 330 MG 24HR Extended Release Oral TabletPSN1544a657-353c-47f8-96ac-a63fa78373f01
1988980pregabalin 82.5 MG 24HR Extended Release Oral TabletPSN1544a657-353c-47f8-96ac-a63fa78373f01
198897424 HR pregabalin 165 MG Extended Release Oral TabletSCD1544a657-353c-47f8-96ac-a63fa78373f01
198897724 HR pregabalin 330 MG Extended Release Oral TabletSCD1544a657-353c-47f8-96ac-a63fa78373f01
198898024 HR pregabalin 82.5 MG Extended Release Oral TabletSCD1544a657-353c-47f8-96ac-a63fa78373f01

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
50228-464-0550228046405500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-464-05) 2022-09-140000-00-00NoNoCurrent
50228-464-305022804643030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-464-30) 2022-09-140000-00-00NoNoCurrent